Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Daurismo (glasdegib)
i
Other names:
PF-04449913, PF 04449913, PF04449913, PF 04, PF-4449913, PF 4449913, PF4449913, PF-04, PF04
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Pfizer
Drug class:
Hedgehog cell-signalling pathway inhibitor, SMO protein inhibitor
Related drugs:
‹
vismodegib (14)
sonidegib (11)
GANT61 (2)
cyclopamine (2)
IPI 926 oral (2)
GANT1 (1)
BMS-833923 (0)
GT1708F (0)
Oxy210 (0)
SUBA-itraconazole (0)
IPI-926 topical (0)
ENV 101 (0)
ZSP1602 (0)
vismodegib (14)
sonidegib (11)
GANT61 (2)
cyclopamine (2)
IPI 926 oral (2)
GANT1 (1)
BMS-833923 (0)
GT1708F (0)
Oxy210 (0)
SUBA-itraconazole (0)
IPI-926 topical (0)
ENV 101 (0)
ZSP1602 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Acute Myelogenous Leukemia
No biomarker
Acute Myelogenous Leukemia
glasdegib
Sensitive: A1 - Approval
glasdegib
Sensitive
:
A1
glasdegib
Sensitive: A1 - Approval
glasdegib
Sensitive
:
A1
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login